ss 37 Search Results


94
Shanghai Korain Biotech Co Ltd chromogranin a
Chromogranin A, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromogranin a/product/Shanghai Korain Biotech Co Ltd
Average 94 stars, based on 1 article reviews
chromogranin a - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

95
Chem Impex International acrylamide aam
Acrylamide Aam, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/acrylamide aam/product/Chem Impex International
Average 95 stars, based on 1 article reviews
acrylamide aam - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

90
Boster Bio chromogranin
Case study of a patient with aggressive prostate cancer. A, CT scan of diffuse liver metastases that appeared in the presence of declining PSA after the patient failed treatment with Zytiga (abiraterone). B, Strong staining for CD133 was detected in the liver metastases using HA10. C, No staining for the AR was observed in the liver metastases using an antibody specific to the N-terminal domain of the AR. This antibody would detect both full-length AR and AR splice variants. D, Staining was observed for the neuroendocrine differentiation marker <t>chromogranin</t> A in the liver metastases. E, An original TURP specimen from the patient depicting poorly differentiated Gleason 4 + 5 cancer stained for CD133. Note the complete absence of CD133. F, Liver biopsy from the patient after failing treatment with carboplatin and taxotere documenting moderate staining for CD133. Scale bars, (B-D) 200 μm and (E-F) 60 μm. [Color figure can be viewed at wileyonlinelibrary.com]
Chromogranin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromogranin/product/Boster Bio
Average 90 stars, based on 1 article reviews
chromogranin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Sanyo fluorescent lamps sanyo fl 40 ss w/37
Case study of a patient with aggressive prostate cancer. A, CT scan of diffuse liver metastases that appeared in the presence of declining PSA after the patient failed treatment with Zytiga (abiraterone). B, Strong staining for CD133 was detected in the liver metastases using HA10. C, No staining for the AR was observed in the liver metastases using an antibody specific to the N-terminal domain of the AR. This antibody would detect both full-length AR and AR splice variants. D, Staining was observed for the neuroendocrine differentiation marker <t>chromogranin</t> A in the liver metastases. E, An original TURP specimen from the patient depicting poorly differentiated Gleason 4 + 5 cancer stained for CD133. Note the complete absence of CD133. F, Liver biopsy from the patient after failing treatment with carboplatin and taxotere documenting moderate staining for CD133. Scale bars, (B-D) 200 μm and (E-F) 60 μm. [Color figure can be viewed at wileyonlinelibrary.com]
Fluorescent Lamps Sanyo Fl 40 Ss W/37, supplied by Sanyo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescent lamps sanyo fl 40 ss w/37/product/Sanyo
Average 90 stars, based on 1 article reviews
fluorescent lamps sanyo fl 40 ss w/37 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Case study of a patient with aggressive prostate cancer. A, CT scan of diffuse liver metastases that appeared in the presence of declining PSA after the patient failed treatment with Zytiga (abiraterone). B, Strong staining for CD133 was detected in the liver metastases using HA10. C, No staining for the AR was observed in the liver metastases using an antibody specific to the N-terminal domain of the AR. This antibody would detect both full-length AR and AR splice variants. D, Staining was observed for the neuroendocrine differentiation marker chromogranin A in the liver metastases. E, An original TURP specimen from the patient depicting poorly differentiated Gleason 4 + 5 cancer stained for CD133. Note the complete absence of CD133. F, Liver biopsy from the patient after failing treatment with carboplatin and taxotere documenting moderate staining for CD133. Scale bars, (B-D) 200 μm and (E-F) 60 μm. [Color figure can be viewed at wileyonlinelibrary.com]

Journal: The Prostate

Article Title: The identification of a novel antibody for CD133 using human antibody phage display

doi: 10.1002/pros.23656

Figure Lengend Snippet: Case study of a patient with aggressive prostate cancer. A, CT scan of diffuse liver metastases that appeared in the presence of declining PSA after the patient failed treatment with Zytiga (abiraterone). B, Strong staining for CD133 was detected in the liver metastases using HA10. C, No staining for the AR was observed in the liver metastases using an antibody specific to the N-terminal domain of the AR. This antibody would detect both full-length AR and AR splice variants. D, Staining was observed for the neuroendocrine differentiation marker chromogranin A in the liver metastases. E, An original TURP specimen from the patient depicting poorly differentiated Gleason 4 + 5 cancer stained for CD133. Note the complete absence of CD133. F, Liver biopsy from the patient after failing treatment with carboplatin and taxotere documenting moderate staining for CD133. Scale bars, (B-D) 200 μm and (E-F) 60 μm. [Color figure can be viewed at wileyonlinelibrary.com]

Article Snippet: The following primary antibodies and concentrations used were: CD133 HA10 antibody, rabbit monoclonal (1:100); androgen receptor SP107 (Sigma), rabbit monoclonal (1:200); chromogranin A PB9097 (Boster Biological Technology) rabbit polyclonal (1:1000); CD133/1 (AC133) (Miltenyi) mouse monoclonal (1:25).

Techniques: Computed Tomography, Staining, Marker